Regulatory Knowledge and Support Core

The CCTS Regulatory Knowledge and Support Core integrates faculty, staff, and community expertise in bioethics, regulatory knowledge, and research integrity to provide investigators, community practitioners, trainees, and research participants with a single point of access to the spectrum of ethical and regulatory requirements.

The core is comprised of highly trained regulatory specialists who can provide support to investigators that is tailored to their specific needs.

Scientist Pipetting at a Biomedical Laboratory
New! Remote Monitoring for Clinical Trials
Illustrated image of an open laptop computer between a smartphone and file folders


We are pleased to announce a plan for remote clinical trial monitoring.

This plan will give study monitors view-only access to the Electronic Medical Record and offers options for monitoring documents outside of the EMR using existing platforms at UK.

Impact

250

Regulatory Services Provided 2016-2019

20

QA Reviews Completed by the Regulatory Core in 2019

91%

Satisfaction Rate for Regulatory Services 

Regulatory Knowledge and Support News

  • Behind the Blue logo
    • Oct 13 2020

    Dr. Lisa Cassis, UK’s vice president for research, oversees the university’s vast medical and nonmedical research efforts. On this episode of "Behind the Blue," she discusses the many areas UK's Office of Research is prioritizing, including greater diversity and inclusion, the increasing commitment to opportunities for undergraduate research, returning research efforts to higher capacity during the COVID-19 pandemic, and more.

  • UK researcher Jeremy Wood, pictured in his lab wearing a white coat, is co-leading research that may provide answers for why so many COVID-19 patients experience blood clotting.
    • Sep 17 2020

    The study suggests that localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients, and that the risk of thrombosis could persist after the infection clears.

  • Illustration of a COVID-19 particle
    • Jun 9 2020

    The program is a collaboration of the UK CURE Alliance and Center for Clinical and Translational Science, who together moved the funding mechanism from concept to first award in 20 days.